PT1238086E - Vacina para aumentar as respostas imunes a vacina contra virus herpes simples - Google Patents

Vacina para aumentar as respostas imunes a vacina contra virus herpes simples

Info

Publication number
PT1238086E
PT1238086E PT00983967T PT00983967T PT1238086E PT 1238086 E PT1238086 E PT 1238086E PT 00983967 T PT00983967 T PT 00983967T PT 00983967 T PT00983967 T PT 00983967T PT 1238086 E PT1238086 E PT 1238086E
Authority
PT
Portugal
Prior art keywords
vaccine
type
hsv
nucleic acid
protein
Prior art date
Application number
PT00983967T
Other languages
English (en)
Inventor
Eric M Mishkin
Robert J Natuk
Michael W Pride
Maninder K Sidhu
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PT1238086E publication Critical patent/PT1238086E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55538—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT00983967T 1999-12-17 2000-12-07 Vacina para aumentar as respostas imunes a vacina contra virus herpes simples PT1238086E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17231399P 1999-12-17 1999-12-17

Publications (1)

Publication Number Publication Date
PT1238086E true PT1238086E (pt) 2006-07-31

Family

ID=22627181

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00983967T PT1238086E (pt) 1999-12-17 2000-12-07 Vacina para aumentar as respostas imunes a vacina contra virus herpes simples

Country Status (16)

Country Link
EP (1) EP1238086B1 (pt)
JP (1) JP2003517042A (pt)
KR (1) KR100773390B1 (pt)
CN (1) CN1222619C (pt)
AT (1) ATE319833T1 (pt)
AU (1) AU783730B2 (pt)
BR (1) BR0016419A (pt)
CA (1) CA2406678A1 (pt)
CY (1) CY1105604T1 (pt)
DE (1) DE60026588T2 (pt)
DK (1) DK1238086T3 (pt)
ES (1) ES2258987T3 (pt)
IL (1) IL149810A0 (pt)
MX (1) MXPA02005867A (pt)
PT (1) PT1238086E (pt)
WO (1) WO2001044477A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003291365B2 (en) * 2002-11-07 2009-06-11 Synergy America, Inc. Compositions and methods for treating or preventing pneumococcal infection
EP3756684A1 (en) 2009-05-22 2020-12-30 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
KR101008582B1 (ko) * 2010-09-20 2011-01-17 (주)칠칠공사 달비계용 2중 안전 샤클조립체
JP6055776B2 (ja) 2010-11-24 2016-12-27 ジェノセア バイオサイエンシーズ， インコーポレイテッド 単純ヘルペスウイルス２型に対するワクチン：免疫応答を誘発する組成物及び方法
AU2012340712B2 (en) 2011-11-23 2017-09-14 Genocea Biosciences, Inc. Nucleic acid vaccines against Herpes Simplex Virus type 2: compositions and methods for eliciting an immune response
WO2014107731A1 (en) 2013-01-07 2014-07-10 Biomedical Research Models, Inc. Therapeutic vaccines for treating herpes simplex virus type 2 infections
EP3943106A1 (en) 2014-03-03 2022-01-26 Albert Einstein College of Medicine Recombinant herpes simplex virus 2 (hsv-2) vaccine vectors
US10918712B2 (en) 2014-03-03 2021-02-16 Albert Einstein College Of Medicine Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
CN104721839A (zh) * 2015-03-17 2015-06-24 浙江省医学科学院 一种预防单纯疱疹病毒ii型的疫苗
CN104830781A (zh) * 2015-05-05 2015-08-12 杨光华 基于hsv-2抗原的dc细胞、靶向性免疫细胞群及其制备方法和用途
US10350288B2 (en) 2016-09-28 2019-07-16 Genocea Biosciences, Inc. Methods and compositions for treating herpes
EP3655016A1 (en) * 2017-07-17 2020-05-27 CHU de Nantes - Centre Hospitalier Universitaire de Nantes Interleukin 12 (il12) or derivative thereof for use in the treatment of secondary disease
WO2019044925A1 (ja) * 2017-08-30 2019-03-07 Ｋｍバイオロジクス株式会社 改変型ＨＳＶ ｇＤタンパク質及びこれを含むワクチン

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002502884A (ja) * 1998-02-12 2002-01-29 アメリカン・サイアナミド・カンパニー インターロイキン−１２および単純ヘルペスウイルス抗原を含んでなるワクチン

Also Published As

Publication number Publication date
EP1238086B1 (en) 2006-03-08
IL149810A0 (en) 2002-11-10
DE60026588D1 (de) 2006-05-04
DK1238086T3 (da) 2006-06-26
AU2065101A (en) 2001-06-25
MXPA02005867A (es) 2002-10-23
CY1105604T1 (el) 2010-07-28
CN1434864A (zh) 2003-08-06
ATE319833T1 (de) 2006-03-15
DE60026588T2 (de) 2007-01-18
BR0016419A (pt) 2002-08-20
CA2406678A1 (en) 2001-06-21
AU783730B2 (en) 2005-12-01
EP1238086A1 (en) 2002-09-11
KR100773390B1 (ko) 2007-11-09
WO2001044477A1 (en) 2001-06-21
KR20020073348A (ko) 2002-09-23
CN1222619C (zh) 2005-10-12
ES2258987T3 (es) 2006-09-16
JP2003517042A (ja) 2003-05-20

Similar Documents

Publication Publication Date Title
PT1238086E (pt) Vacina para aumentar as respostas imunes a vacina contra virus herpes simples
BRPI0408779A (pt) uso de composições, composição imunogênica e kit
FI953608A7 (fi) Rokoteyhdisteet ja menetelmä immuunireaktion aikaansaamiseksi limakalv ossa järjestelmällisellä rokottamisella
KR0176265B1 (en) Causative agent of the mystery swine disease, and vaccine compositions
BG101103A (bg) Теломераза при бозайници
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
DK1326636T3 (da) Vaccinesammensætning
EP1847549A3 (en) Papillomavirus polyprotein constructs
WO2002061113A3 (en) Nucleic acid derived vaccine that encodes an antigen linked to a polypeptide that promotes antigen presentation
EP1326633A4 (en) COMPOSITION WITH IMMUNOGENIC MICROPARTICLES
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
PT1187629E (pt) Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador
WO2000020027A3 (en) Methods for therapeutic vaccination
MX9401225A (es) Composicion de vacuna para prevenir la infeccion con influenza en humanos y metodo para su preparacion.
IL106968A0 (en) Potentiation of immunogenic response
BR0014138A (pt) Uso de um vetor adenoviral deficiente em replicação, e, métodos para reforçar, e para induzir resposta imune de célula cd8+ t a um antìgeno em um indivìduo
BR0207528A (pt) Anticorpo, composição farmacêutica, e, usos de uma quantidade efetiva de um agente, de uma quantidade terapeuticamente efetiva de um anticorpo para il-22, de uma quantidade imunogênica do antìgeno e uma quantidade aumentadora de imunogenicidade de il-22 em combinação, de uma quantidade efetiva do anticorpo ou fragmento do mesmo e de uma quantidade suficiente de anticorpo ou fragmento ligado a antìgeno do mesmo
BR9710849A (pt) Vacina contendo uma peróxi-redoxina e/ou uma beta-tubulina.
ATE381351T1 (de) Anwendung des herpes simplex virus glykoproteins- d zur unterdrückung von immunantworten
DE60239753D1 (de) Impfstoff gegen infektiöses lachsanämievirus
BR0011478A (pt) Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal
BR0013574A (pt) Antìgeno vacina de moraxella
BR0112486A (pt) Poliproteìna, molécula de ácido nucleico, plasmìdeo, vacina recombinante ou vacina atenuada, composição farmacêutica, e, método para imunizar um indivìduo contra hiv
ATE374622T1 (de) Genetische impstoffe mit adjuvans
BR9905780A (pt) Antìgenos vacinais de leptospira para prevenção da laptospirose